logo

Allogene Therapeutics, Inc. (ALLO)



Trade ALLO now with
  Date
  Headline
8/7/2019 7:53:53 AM Allogene Therapeutics Q2 Net Loss $41.2 Mln Or $0.41/Shr Vs Loss Of $134.9 Mln Or $43.82/Shr Last Year
1/17/2019 12:37:40 PM PayPal Appoints Deborah Messemer To Its Board Of Directors
12/3/2018 7:56:02 PM Allogene, Servier Present Data From Phase 1 Trials Of Allogeneic UCART19 In Relapsed/RAL Leukemia
10/7/2018 11:28:35 PM This Week's Biotech IPOs